Gainers
- Sagimet Biosciences SGMT stock rose 103.5% to $13.88 during Monday's regular session. The company's market cap stands at $317.8 million.
- Bullfrog AI Hldgs BFRG shares moved upwards by 41.1% to $6.9. The market value of their outstanding shares is at $42.0 million.
- Bone Biologics BBLG shares increased by 32.3% to $4.3. The market value of their outstanding shares is at $2.2 million.
- 60 Degrees SXTP stock moved upwards by 26.19% to $0.79. The company's market cap stands at $4.5 million.
- AquaBounty Techs AQB stock rose 25.65% to $2.4. The company's market cap stands at $9.2 million.
- BIMI Intl Medical BIMI shares increased by 22.13% to $2.71. The company's market cap stands at $37.9 million.
Losers
- Virios Therapeutics VIRI shares declined by 37.1% to $0.51 during Monday's regular session. The company's market cap stands at $9.8 million.
- Shuttle Pharmaceuticals SHPH shares declined by 24.04% to $0.4. The company's market cap stands at $6.3 million.
- NexImmune NEXI stock fell 20.11% to $5.59. The company's market cap stands at $5.9 million.
- Synaptogenix SNPX stock decreased by 19.52% to $0.19. The market value of their outstanding shares is at $3.9 million.
- CNS Pharma CNSP shares declined by 18.52% to $0.64. The market value of their outstanding shares is at $3.9 million.
- Elicio Therapeutics ELTX shares decreased by 17.95% to $3.85. The company's market cap stands at $36.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AQBAquaBounty Technologies Inc
$0.7600-3.28%
Edge Rankings
Momentum
15.99
Price Trend
Short
Medium
Long
BBLGBone Biologics Corp
$2.94-2.65%
BFRGBullfrog AI Holdings Inc
$1.541.25%
BIMIBIMI Holdings Inc
$0.000109900.0%
CNSPCNS Pharmaceuticals Inc
$0.9063-0.13%
ELTXElicio Therapeutics Inc
$8.17-1.21%
NEXINexImmune Inc
$0.00010-%
SGMTSagimet Biosciences Inc
$9.48-4.34%
SHPHShuttle Pharmaceuticals Holdings Inc
$4.02-5.30%
SXTP60 Degrees Pharmaceuticals Inc
$2.703.43%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.